Everything below concerns Freeze-thaw. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-12-30. Numbers and descriptions here follow the published literature rather than marketing material.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or oxidised impurities. Mass spectrometry, most often coupled to liquid chromatography, confirms molecular mass and detects substitutions that chromatography alone may miss. Amino acid analysis and peptide mapping supply additional structural evidence, while nuclear magnetic resonance is reserved for full structural confirmation. Laboratories that examine samples sold online report wide variation in actual content, with some vials containing little or none of the labelled material.
Melanotan-2 appears on the World Anti-Doping Agency prohibited list within the peptide hormone class, and several national regulators treat it as an unapproved prescription substance. Some countries restrict importation or sale for personal use. Because the compound is widely traded as a research chemical, the practical legal picture differs between jurisdictions and shifts over time. Human safety data covering long periods are limited, and whether repeated pigmentation changes carry any lasting risk to melanocytes remains an open question.
Verification of a purchased sample requires documentation linking a batch to a certificate of analysis, and that document should be read for the methods used rather than the headline purity figure. A single chromatographic percentage does not establish identity. Independent laboratories can perform identity and content assays, but no such test establishes that a product is suitable for human use. Claims about efficacy rest largely on small, early studies rather than on replicated controlled trials, and that gap remains open.
Identity testing for a cyclic peptide of this size usually relies on reversed-phase high-performance liquid chromatography coupled to mass spectrometry. The mass spectrum confirms molecular weight, while the chromatographic trace indicates the proportion of related impurities. Tandem mass spectrometry can provide sequence-level information when fragmentation data are compared against a reference standard. Nuclear magnetic resonance is sometimes used to confirm the lactam bridge, although it requires more material and greater operator expertise than routine chromatographic methods.
Lyophilised peptide powder is comparatively stable when kept dry, cold and protected from light. Once dissolved, the molecule is exposed to hydrolysis, oxidation and microbial growth, and degradation accelerates at higher temperatures and in alkaline solution. Repeated freeze-thaw cycles concentrate solutes and promote aggregation. Handling guidance for research peptides commonly clusters around freezer temperatures for powder and short refrigerated use for reconstituted solutions, with pH control and sterile technique applied throughout.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C or below | For the lyophilised powder, desiccated |
| Storage form | Sealed vial, protected from light | Amber glass or foil-wrapped containers |
| Reconstituted stability | Short, refrigerate | Degradation accelerates in solution |
| Typical analytical method | Reversed-phase HPLC with mass spectrometry | Purity assessment plus identity confirmation |
| Common synonyms | Melanotan II, MT-II | Also written melanotan-2 |
Regulatory status differs by country, and in many places supplying the compound for human consumption is unlawful. Vendors frequently label material as intended for research use only, a designation that shifts stated purpose but does not create a legal pathway for personal use. Certificates of analysis accompanying such products vary widely in detail and provenance. Third-party testing exists but is voluntary, and results are rarely linked to a specific lot in a publicly verifiable way.
Identity testing for a synthetic peptide relies on several complementary methods. Reversed-phase high-performance liquid chromatography separates the target from related impurities and reports purity as a percentage of total peak area. Mass spectrometry confirms molecular mass and can reveal deletions or truncations. Amino acid analysis and peptide mapping provide sequence-level confirmation, while counter-ion content and residual solvents are measured separately. A purity figure alone does not establish identity, so a complete dataset combines chromatographic and spectrometric evidence.
== Etymology == The scientific name Nelumbo nucifera comes from a Sinhalese name for the plant, nelambu or nelum (නෙළඹු or නෙළුම්), and the Latin word 'nucifera', meaning "nut-bearing". Therefore, the full name translates to "nut-bearing nelumbo", referring to the plant's edible, nut-like seeds.
== Cameroon == Modibbo Adama – Islamic scholar and first emir of Adamawa (Both Cameroon and Nigerian Adamawa) Ahmadou Ahidjo – first president, Cameroon (1960–1982) Bello Bouba Maigari – former prime minister, Cameroon Sadou Hayatou – former prime minister, Cameroon Issa Hayatou – former president of the Confederation of African Football (CAF), former acting president FIFA, Cameroon Oumarou Fadil – Businessman, Vice President of Group Fadil (an agro-industrial group which operates in several sectors including soap, oil extraction, tourism, livestock, and new information technologies), Cameroon Djaili Amadou Amal – Writer and feminist activist, Cameroon Goggo Addi – Storyteller who worked to preserve Fulani cultural heritage Souleymanou Hamidou Germaine Ahidjo - former first lady, Cameroon (1960–1982) Youssoufa Daoua (1947–2015), Cameroonian politician Mohamadou Bayero Fadil, Cameroonian businessman Abbo Aboubakar, Cameroonian businessman and politician Baba Ahmadou Danpullo, Cameroonian businessman Nana Bouba, Cameroonian businessman Marafa Hamidou Yaya, Cameroonian politician Garga Haman Adji, Cameroonian politician Mohamadou Dabo, Cameroonian businessman
The known amino acids to be targeted in the protein are tyrosine and threonine, and sometimes serine. When charges on a protein undergo a change, it affects the characteristics of the protein, normally by altering its shape via interactions of the amino acids which make up the protein. AMPylation can have various effects on the protein. These are properties of the protein like, stability, enzymatic activity, co-factor binding, and many other functional capabilities of a protein. Another function of adenylylation is amino acids activation, which is catalyzed by tRNA aminoacyl synthetase. The most commonly identified protein to receive AMPylation are GTPases, and glutamine synthetase.
4-HO-DPT acts as a high-efficacy partial agonist to full agonist of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors. It has more than two orders of magnitude greater potency as an agonist of the serotonin 5-HT2A and 5-HT2B receptors than as an agonist of the serotonin 5-HT2C receptor. Hence, it shows considerable selectivity for the serotonin 5-HT2A receptor over the serotonin 5-HT2C receptor. Compared to psilocin (4-HO-DMT), 4-HO-DPT has about the same potency and efficacy as a serotonin 5-HT2A receptor agonist, has about the same potency but is much more efficacious as a serotonin 5-HT2B receptor agonist (EmaxTooltip maximal efficacy = 39% vs. 94%, respectively), and has about the same efficacy but approximately 10-fold lower potency as a serotonin 5-HT2C receptor agonist. 4-HO-DPT produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents. Its potency for inducing the head-twitch response in mice is about 4- or 5-fold lower than that of psilocin.
Valerie Horsley is an American cell and developmental biologist. She currently works as an associate professor at Yale University, where she has extensively researched the growth, restoration, and maintenance of skin cells. She is a currently a member of the Yale Cancer Center and Yale Stem Cell Center. She received a Presidential Early Career Award for Scientists and Engineers in 2012 and in 2013 she was the recipient of the Rosalind Franklin Young Investigator Award.
Sources: en.wikipedia.org
Roosevelt quickly understood the implications, stating, "Alex, what you are after is to see that the Nazis don't blow us up." Roosevelt ordered the formation of the Advisory Committee on Uranium. In February 1940, encouraged by Fermi and John R. Dunning, Alfred O. C. Nier was able to separate U-235 and U-238 from uranium tetrachloride in a glass mass spectrometer. Subsequently, Dunning, bombarding the U-235 sample with neutrons generated by the Columbia University cyclotron, confirmed "U-235 was responsible for the slow neutron fission of uranium." At the University of Birmingham, Frisch teamed up with Rudolf Peierls, who had been working on a critical mass formula. assuming isotope separation was possible, they considered 235U, which had a cross section not yet determined, but which was assumed to be much larger than that of natural uranium. They calculated only a pound or two in a volume less than a golf ball, would result in a chain reaction faster than vaporization, and the resultant explosion would generate temperature greater than the interior of the sun, and pressures greater than the center of the earth. Additionally, the costs of isotope separation "would be insignificant compared to the cost of the war." By March 1940, encouraged by Mark Oliphant, they wrote the Frisch–Peierls memorandum in two parts, "On the construction of a 'super-bomb; based on a nuclear chain reaction in uranium," and "Memorandum on the properties of a radioactive 'super-bomb.' ". On 10 April 1940, the first meeting of the MAUD Committee was held.
==== Drugs with unknown mechanisms of action ==== Amantadine (Symmetrel) – unknown mechanism of action and ionotropic glutamate NMDA receptor antagonist (indirect dopaminergic agent) Amantadine extended release (ADS-5101; ADS-5102; Gocovri; Nurelin) – unknown mechanism of action and ionotropic glutamate NMDA receptor antagonist (indirect dopaminergic agent) – drug-induced dyskinesia in Parkinson's disease [343] Budipine (BY-701; Parkinsan) – unknown mechanism of action and ionotropic glutamate NMDA receptor antagonist [344]
== References == Ashton, Harry E. (1995). "Architectural Coatings". In Koleske, Joseph V. (ed.). Paint and Coating Testing Manual: 14th Edition of the Gardner–Sward Handbook. ASTM International. ISBN 0803120605. Retrieved 10 January 2016.
== Choice of base formulation == A medication's potency often is changed with its base. For example, some topical steroids will be classified one or two strengths higher when moving from cream to ointment. As a rule of thumb, an ointment base is more occlusive and will drive the medication into the skin more rapidly than a solution or cream base. The manufacturer of each topical product has total control over the content of the base of a medication. Although containing the same active ingredients, one manufacturer's cream might be more acidic than the next, which could cause skin irritation or change its absorption rate. For example, a vaginal formulation of miconazole antifungal cream might irritate the skin less than an athlete's foot formulation of miconazole cream. These variations can, on occasion, result in different clinical outcomes, even though the active ingredient is the same. No comparative potency labeling exists to ensure equal efficacy between brands of topical steroids (percentage of oil vs water dramatically affect the potency of topical steroid). Studies have confirmed that the potency of some topical steroid products may differ according to manufacturer or brand. An example of this is the case of brand name Valisone cream and Kenalog cream in clinical studies have demonstrated significantly better vasoconstrictions than some forms of this drug produced by generic drug manufacturers. However, in a simple base like an ointment, much less variation between manufacturers is common.
== Facilities == The UNC School of Medicine operates across 28 buildings on the southwest side of the UNC campus. Most academic activities take place in Bondurant Hall and Roper Hall, both of which have direct access to the UNC Medical Center. Eleven research buildings, including wet labs, offices, and meeting spaces, are located just south of the academic buildings, which include Marsico Hall, the Mary Ellen Jones Building, and the Lineberger Cancer Research Center. Additional support facilities are spread out across UNC's campus and the surrounding neighborhoods.
Sources: en.wikipedia.org
== Further reading == López-Alonso, JP; Diez-Garcia, F; Font, J; Ribó, M; Vilanova, M; Scholtz, JM; González, C; Vottariello, F; Gotte, G; Libonati, M; Laurents, DV (2009). "Carbodiimide EDC Induces Cross-Links That Stabilize RNase A C-dimer against Dissociation: EDC Adducts Can Affect Protein Net Charge, Conformation and Activity". Bioconjugate Chemistry. 20 (8): 1459–1473. doi:10.1021/bc9001486. PMID 19606852. Nakajima, N; Ikada, Y (1995). "Mechanism of Amide Formation by Carbodiimide for Bioconjugation in Aqueous Media". Bioconjugate Chemistry. 6 (1): 123–130. doi:10.1021/bc00031a015. PMID 7711098.
From clinical trials, only 14% of heart attacks occur from artery closure at plaques producing 75% or greater stenosis before the vessel closing. If the fibrous cap separating a soft atheroma from the bloodstream within the artery ruptures, tissue fragments are exposed and released. These tissue fragments are very clot-promoting, containing collagen and tissue factor; they activate platelets and activate the system of coagulation. The result is the formation of a thrombus (blood clot) overlying the atheroma, which obstructs blood flow acutely. With the obstruction of blood flow, downstream tissues are starved of oxygen and nutrients. If this is the myocardium (heart muscle) angina (cardiac chest pain) or myocardial infarction (heart attack) develops.
== Mineralization of bone == The mechanisms of mineralization are not fully understood. Fluorescent, low-molecular weight compounds such as tetracycline or calcein bind strongly to bone mineral, when administered for short periods. They then accumulate in narrow bands in the new bone. These bands run across the contiguous group of bone-forming osteoblasts. They occur at a narrow (sub-micrometer) mineralization front. Most bone surfaces express no new bone formation, no tetracycline uptake and no mineral formation. This strongly suggests that facilitated or active transport, coordinated across the bone-forming group, is involved in bone formation, and that only cell-mediated mineral formation occurs. That is, dietary calcium does not create mineral by mass action. The mechanism of mineral formation in bone is clearly distinct from the phylogenetically older process by which cartilage is mineralized: tetracycline does not label mineralized cartilage at narrow bands or in specific sites, but diffusely, in keeping with a passive mineralization mechanism. Osteoblasts separate bone from the extracellular fluid by tight junctions by regulated transport. Unlike in cartilage, phosphate and calcium cannot move in or out by passive diffusion, because the tight osteoblast junctions isolate the bone formation space. Calcium is transported across osteoblasts by facilitated transport (that is, by passive transporters, which do not pump calcium against a gradient).
==== Autonomic problems ==== Although neurogastroenterological manifestations in connective tissue disorders are common, their root cause is not yet known. Splanchnic circulation, small fiber neuropathy and altered vascular compliance have all been named as potential contributors to gastrointestinal complaints, particularly for patients who have a known, comorbid autonomic condition. Dysautonomia symptoms, autonomic system dysfunction, in hEDS is associated with exercise intolerance and cardiac atrophy.
== Synthesis == In the radiopharmaceutical industry, fluorine-18 is made using either a cyclotron or linear particle accelerator to bombard a target, usually of natural or enriched [18O]water with high energy protons (typically ~18 MeV). The fluorine produced is in the form of a water solution of [18F]fluoride, which is then used in a rapid chemical synthesis of various radiopharmaceuticals. This must be done after the fluorine is produced, as chemical bonds would be destroyed by the production (radiolysis).
Sources: en.wikipedia.org
The lyophilised solid is best kept cold, dry and dark, typically at minus twenty degrees Celsius. Moisture and repeated warming cycles are the main causes of degradation. Solutions prepared from the powder are less stable and are normally used quickly.
Reversed-phase liquid chromatography assesses purity, while mass spectrometry confirms molecular mass and detects sequence errors. Amino acid analysis and peptide mapping add structural detail. These techniques are complementary rather than interchangeable.
It is listed as a prohibited peptide hormone by the World Anti-Doping Agency. No medicines regulator has approved it for human use. Import and sale rules vary by country.
Mass spectrometry combined with liquid chromatography provides both molecular weight confirmation and a measure of related impurities. Tandem mass spectrometry adds sequence information. A purity percentage reported without a mass measurement does not confirm what the material is.